This is the authors' abstract. We don't add key points for this paper.
HA is common in EM women and is associated with increased risks for MetS and dysglycemia. However, low SHBG levels rather than elevated androgen levels may be the primary predictor of this relationship with metabolic dysfunction.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Torchen et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: